Moxifloxacinum Misom, (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moxifloxacinum Misom, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial conjunctivitis and bacterial keratitis in patients requiring topical eye therapy.

GNH USA supplies Moxifloxacinum Misom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacinum Misom is a fluoroquinolone ophthalmic antibacterial used to manage bacterial eye infections.

- Bacterial conjunctivitis: reduces bacterial load and resolves redness and discharge. - Bacterial keratitis: eradicates pathogenic bacteria to prevent corneal damage. - Post‑operative ocular infection: prevents or treats infection following eye surgery.

Moxifloxacinum Misom may cause ocular and systemic reactions.

Common Side Effects: - Eye irritation: mild burning or stinging on instillation. - Redness: transient conjunctival hyperemia. - Blurred vision: temporary visual disturbance after dosing. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash, or hives requiring medical attention. - Stevens‑Johnson syndrome: severe skin and mucous membrane involvement. - Corneal ulceration: worsening corneal lesions despite therapy. - Anaphylaxis: rapid onset of systemic hypersensitivity. - Severe ocular inflammation: marked pain, photophobia, and vision loss.

Before prescribing Moxifloxacinum Misom, consider the following safety measures.

- Allergy assessment: avoid if known hypersensitivity to fluoroquinolones. - Contact lens use: discontinue lenses during treatment to reduce irritation. - Corneal ulcer monitoring: assess response and adjust therapy if condition worsens. - Pregnancy safety: use only if potential benefit justifies potential risk. - Pediatric use: safety and efficacy not established in children. - Store at room temperature: keep in original container, protect from light and moisture.

Moxifloxacinum Misom can interact with other ophthalmic and systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase systemic exposure. - Corticosteroid eye drops: may heighten risk of secondary infection. - Anticholinergic eye drops: can reduce drug absorption. - Tetracycline antibiotics: potential for additive phototoxicity. - Non‑steroidal anti‑inflammatory eye drops: may impair healing.

Moderate Interactions (Monitor Closely): - Other topical antibiotics: assess for additive toxicity. - Ocular anesthetics: monitor for delayed corneal healing. - Herbal supplements (e.g., St. John’s wort): may affect metabolism. - Vitamin A derivatives: watch for altered ocular surface response.